Comments
Loading...

Ocular Therapeutix

OCULNASDAQ
Logo brought to you by Benzinga Data
$9.05
0.293.31%
At Close: -
$9.32
0.272.96%
After Hours: 5:35 PM EDT
15 minutes delayed
Consensus Rating1
Buy
Highest Price Target1
$22.00
Lowest Price Target1
$11.00
Consensus Price Target1
$15.38

Ocular Therapeutix (NASDAQ:OCUL) Stock, Analyst Ratings, Price Targets, Forecasts

Ocular Therapeutix Inc has a consensus price target of $15.38 based on the ratings of 8 analysts. The high is $22 issued by JMP Securities on May 8, 2024. The low is $11 issued by TD Cowen on June 20, 2024. The 3 most-recent analyst ratings were released by Baird, HC Wainwright & Co., and Piper Sandler on August 8, 2024, August 1, 2024, and June 21, 2024, respectively. With an average price target of $15.33 between Baird, HC Wainwright & Co., and Piper Sandler, there's an implied 64.56% upside for Ocular Therapeutix Inc from these most-recent analyst ratings.

Analyst Trends and Forecast
0
0
0
0
Apr
0
0
0
0
May
2
Jun
1
Aug
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
4.4
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

Baird
HC Wainwright & Co.
Piper Sandler
TD Cowen
Piper Sandler

1calculated from analyst ratings

Analyst Ratings for Ocular Therapeutix

Data brought to you by Benzinga APIs

FAQ

Q

What is the target price for Ocular Therapeutix (OCUL) stock?

A

The latest price target for Ocular Therapeutix (NASDAQ:OCUL) was reported by Baird on August 8, 2024. The analyst firm set a price target for $17.00 expecting OCUL to rise to within 12 months (a possible 82.44% upside). 19 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Ocular Therapeutix (OCUL)?

A

The latest analyst rating for Ocular Therapeutix (NASDAQ:OCUL) was provided by Baird, and Ocular Therapeutix maintained their outperform rating.

Q

When was the last upgrade for Ocular Therapeutix (OCUL)?

A

The last upgrade for Ocular Therapeutix Inc happened on June 20, 2024 when TD Cowen raised their price target to $11. TD Cowen previously had a hold for Ocular Therapeutix Inc.

Q

When was the last downgrade for Ocular Therapeutix (OCUL)?

A

There is no last downgrade for Ocular Therapeutix.

Q

When is the next analyst rating going to be posted or updated for Ocular Therapeutix (OCUL)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Ocular Therapeutix, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Ocular Therapeutix was filed on August 8, 2024 so you should expect the next rating to be made available sometime around August 8, 2025.

Q

Is the Analyst Rating Ocular Therapeutix (OCUL) correct?

A

While ratings are subjective and will change, the latest Ocular Therapeutix (OCUL) rating was a maintained with a price target of $18.00 to $17.00. The current price Ocular Therapeutix (OCUL) is trading at is $9.32, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch